Scarica l'app Stockscreener
200.53
2.11%
-4.32
Dopo l'orario di chiusura:
200.70
0.17
+0.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DHR Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$204.85
Aprire:
$202.33
Volume 24 ore:
3.01M
Relative Volume:
0.67
Capitalizzazione di mercato:
$140.97B
Reddito:
$24.78B
Utile/perdita netta:
$3.68B
Rapporto P/E:
38.76
EPS:
5.1743
Flusso di cassa netto:
$5.29B
1 W Prestazione:
-4.98%
1M Prestazione:
-4.22%
6M Prestazione:
+2.72%
1 anno Prestazione:
+4.12%
Intervallo 1D:
$200.34
$203.10
Intervallo di 1 settimana:
$200.34
$208.70
Portata 52W:
$160.93
$242.80
Danaher Corp Stock (DHR) Company Profile
Nome
Danaher Corp
Settore
Industria
Telefono
(202) 828-0850
Indirizzo
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, NTRA, IQV, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
200.53 | 144.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
TMO
Thermo Fisher Scientific Inc
|
603.18 | 223.95B | 45.20B | 6.87B | 6.75B | 18.19 |
NTRA
Natera Inc
|
326.14 | 47.61B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
257.30 | 42.30B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
143.12 | 40.81B | 7.23B | 1.41B | 1.09B | 4.979 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-03-14 | Aggiornamento | Stifel | Hold → Buy |
| 2025-02-03 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-31 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Iniziato | HSBC Securities | Hold |
| 2023-12-13 | Ripresa | Wolfe Research | Peer Perform |
| 2023-12-07 | Downgrade | Goldman | Buy → Neutral |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-01 | Iniziato | SVB Securities | Outperform |
| 2023-04-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-10-24 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-08-17 | Ripresa | Bernstein | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-06-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Iniziato | Bernstein | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-10 | Reiterato | BofA Securities | Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Reiterato | Goldman | Buy |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-04-07 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-03 | Ripresa | Barclays | Overweight |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Ripresa | Stifel | Hold |
| 2019-10-28 | Reiterato | Needham | Buy |
| 2019-10-14 | Ripresa | Credit Suisse | Outperform |
| 2019-07-19 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-04-17 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2019-02-25 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-03 | Iniziato | Needham | Buy |
| 2018-04-20 | Reiterato | Stifel | Buy |
Mostra tutto
Danaher Corp Borsa (DHR) Ultime notizie
Danaher Corp. stock underperforms Thursday when compared to competitors - MarketWatch
UBS assumes coverage on Danaher stock with buy rating, $250 target - Investing.com Nigeria
Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says - Yahoo Finance
Danaher Corp. stock gains support from UBS buy rating and July earnings beat - ad-hoc-news.de
Danaher stock heads into the open after a 0.87 percent slip - ad-hoc-news.de
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
Danaher stock holds near $207 after Q2 beat - ad-hoc-news.de
Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others - Yahoo Finance UK
Danaher stock heads into the open after a 0.5 percent dip - ad-hoc-news.de
Danaher Corp stock edges lower as investors weigh latest analyst targets and dividend signal - ad-hoc-news.de
Danaher (NYSE:DHR): Is Its Next Move Tied to Inflation Data? - Kalkine Media
Danaher stock holds after Q2 revenue and EPS beat - AD HOC NEWS
Danaher Corp. stock underperforms Friday when compared to competitors - MarketWatch
Danaher Corp. stock trades near 52-week highs as investors digest recent earnings - AD HOC NEWS
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Danaher (DHR) Seen Deftly Navigating AI Integration - Yahoo Finance
Baird Adjusts Price Target on Danaher to $238 From $232, Keeps Outperform Rating - marketscreener.com
Danaher (DHR) Stock Trades Near Fair Value But At An Earnings Premium - Yahoo Finance
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Danaher Corp. stock holds steady after recent pullback as investors weigh Q2 2026 results - AD HOC NEWS
Danaher (DHR) Stock Looks Fairly Valued On Cash Flow Yet Overvalued On Earnings - simplywall.st
A Look at Danaher Corp (DHR) After 3.1% Decline -- GF Value $242 - GuruFocus
Danaher Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Danaher Corp Stock (DHR) Moved Down by 3.06% on Sep 1: Facts Behind the Movement - TradingKey
HSBC Adjusts Price Target on Danaher to $250 From $230, Maintains Buy Rating - marketscreener.com
Danaher Corp. stock underperforms Monday when compared to competitors - MarketWatch
Is Danaher Stock Underperforming the Nasdaq? - Barchart.com
Why Danaher (DHR) Remains a Healthcare Compounder to Watch - Yahoo Finance
Danaher Rides on Strength in Biotechnology Segment: Will It Sustain? - Eastern Progress
Danaher vs. Intuitive Surgical: Is Recovery or Innovation the Better Long-Term Bet? - Yahoo Finance
Danaher (NYSE: DHR) holder Blair plans $12.7M stock sale - Stock Titan
Resilient Danaher stock edges higher as institutional buying and analyst support frame the outlook - Ad-hoc-news.de
U.S. Market Edge Lower— Danaher Corporation's Bullish Breakout in Focus - kalkine.ca
6,796 Shares in Danaher Corporation $DHR Bought by Portfolio Design Labs LLC - MarketBeat
17 CAPITAL PARTNERS, LLC's Danaher Corp(DHR) Holding History - GuruFocus
10,799 Shares in Danaher Corporation $DHR Acquired by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Somerville Kurt F Purchases Shares of 45,245 Danaher Corporation $DHR - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Makes New Investment in Danaher Corporation $DHR - MarketBeat
932,220 Shares in Danaher Corporation $DHR Bought by Bank of New York Mellon Corp - MarketBeat
Bank of New York Mellon Corp Purchases New Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (NYSE:DHR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Danaher Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Danaher (NYSE:DHR) Valuation Debate Deepens After Life Sciences Progress - Kalkine Media
Integrated DNA Technologies Defines the Next Era of DNA Synthesis: Full-Spectrum Capabilities for Speed, Complexity and Scale - StreetInsider
Madison Asset Management LLC Acquires Shares of 448,611 Danaher Corporation $DHR - MarketBeat
Puzo Michael J Makes New Investment in Danaher Corporation $DHR - MarketBeat
Kentucky Farm Bureau Mutual Insurance Co Buys New Position in Danaher Corporation $DHR - MarketBeat
Tocqueville Asset Management L.P. Purchases Shares of 59,318 Danaher Corporation $DHR - MarketBeat
NewEdge Wealth LLC Invests $4.41 Million in Danaher Corporation $DHR - MarketBeat
Knuff & Co LLC Buys Shares of 6,462 Danaher Corporation $DHR - MarketBeat
Flossbach Von Storch SE Makes New Investment in Danaher Corporation $DHR - MarketBeat
Danaher Corp Azioni (DHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):